Tuning the Physicochemical Characteristics of Particle-Based Carriers for Intraperitoneal Local Chemotherapy
- 3 June 2020
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 37 (6) , 1-24
Abstract
Over the last few decades, intraperitoneal (IP) local drug delivery, providing high drug concentrations with prolonged retention in the peritoneal cavity, has opened a new horizon for the management of life-threatening peritoneal disorders, such as peritoneal carcinomatosis (PC). However, clinical translation of this strategy is hampered by several hurdles, namely premature clearance of small-sized molecules from the peritoneum, limited distribution within the peritoneal space and inadequate penetration into the target tissues. To address these challenges, incorporation of therapeutic agents into the particulate-based drug delivery systems has brought new hope in this direction. Nonetheless, as yet, there has been no formulation specifically approved for IP delivery. To gain this goal, it is crucial to have a detailed understanding of the correlation between the physicochemical characteristics of particle-based carriers and their biological fate and anticancer efficacy after IP administration. The main focus of this review, therefore, concerns the significance of these characteristics, namely composition, particle size, charge, coating and presence of targeting moieties in the design of carriers for successful IP delivery. Physicochemical characteristics of particle-based carriers influence their peritoneal residence time, biological fate and anticancer efficacy after intraperitoneal administrationKeywords
This publication has 157 references indexed in Scilit:
- Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenograftsBMC Cancer, 2013
- Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected databaseBMC Cancer, 2013
- Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold NanoparticlesClinical Cancer Research, 2010
- Drug Delivery Systems for Intraperitoneal TherapyPharmaceutical Research, 2010
- Therapeutic antibodies: successes, limitations and hopes for the futureBritish Journal of Pharmacology, 2009
- Tumor-Penetrating Microparticles for Intraperitoneal Therapy of Ovarian CancerThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistryRadiotherapy and Oncology, 2008
- Combined Resection, Intraperitoneal Chemotherapy, and Whole Abdominal Radiation for the Treatment of Malignant Peritoneal MesotheliomaAmerican Journal of Clinical Oncology, 2008
- Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalizationMicrovascular Research, 2007
- Effects of Carrier on Disposition and Antitumor Activity of Intraperitoneal PaclitaxelPharmaceutical Research, 2007